SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-24-046895
Filing Date
2024-04-15
Accepted
2024-04-15 06:00:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tm2411778d1_424b3.htm 424B3 9283
2 GRAPHIC tm2411778d1_424b3img01.jpg GRAPHIC 4006
  Complete submission text file 0001104659-24-046895.txt   16116
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-265492 | Film No.: 24843025
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)